Triphase Accelerator Overview
- Founded
-
2010
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Early Stage VC
- Investors
-
3
Triphase Accelerator General Information
Description
Developer of novel therapeutics intended to accelerate the development of promising cancer therapies. The company's novel therapeutics focus on accelerating oncology product development from the pre-investigational new drug in less time with less capital than traditional pharma and biotech approaches, enabling cancer patients to get effective, affordable, and improved treatments than traditional drug development.
Contact Information
Website
www.triphaseco.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
- 661 University Avenue
- Suite 465
- Toronto, Ontario M5G 1M1
- Canada
+1 (647) 000-0000
Triphase Accelerator Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 24-Oct-2014 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 09-Jan-2014 | Completed | Generating Revenue |
Triphase Accelerator Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Grant Gibson | Chief Financial Officer | ||
| Raphael Hofstein Ph.D | Co-Founder, Chief Executive Officer & Board Member | ||
| Ilse Treurnicht Ph.D | Chairman |
Triphase Accelerator Board Members (8)
| Name | Representing | Role | Since |
|---|---|---|---|
| David O'Neill Ph.D | Triphase Accelerator | Board Member | 000 0000 |
| Ilse Treurnicht Ph.D | Self | Chairman | 000 0000 |
| Kevin Leshuk | Self | Board Member | 000 0000 |
| Parimal Nathwani | Triphase Accelerator | Board Member | 000 0000 |
| Raphael Hofstein Ph.D | Self | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
Triphase Accelerator Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Triphase Accelerator Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Celgene | Corporation | Minority | 000 0000 | 000000 0 | |
| FACIT | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Toronto Innovation Acceleration Partners | Not-For-Profit Venture Capital | Minority | 000 0000 | 000000 0 |
Triphase Accelerator Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 | 0000000000 | Drug Delivery |